VEON (NASDAQ:VEON) reported quarterly sales of $2.08 million which missed the analyst consensus estimate of $2.05 billion by 99.90 percent. This is a 99.90 percent decrease over sales of $2.00 billion the same period last year.
Credit Suisse Maintains Outperform on Synchrony Finl, Lowers Price Target to $37
Credit Suisse analyst Moshe Orenbuch maintains Synchrony Finl (NYSE:SYF) with a Outperform and lowers the price target from $38 to $37.